| BIM Protein | |
|---|---|
| Gene | [BCL2L11](/genes/bcl2l11) |
| UniProt | O43521 |
| PDB | 2K7W, 1PQ1 |
| Mol. Weight | 22 kDa (multiple isoforms) |
| Localization | Cytoplasm, mitochondrial outer membrane |
| Family | BCL2 family, BH3-only proteins |
| Diseases | [Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als), [FTD](/diseases/ftd) |
Bim Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
BIM (BCL2-like 11, also called BCL2-interacting mediator of cell death) is a potent pro-apoptotic member of the BCL2 family that plays a critical role in regulating neuronal survival and death[1]. BIM is essential for embryonic development and acts as a key initiator of apoptosis in response to various cellular stresses relevant to neurodegeneration[2].
The BCL2L11 gene produces multiple BIM isoforms through alternative splicing, with BIM-EL (extra long), BIM-L (long), and BIM-S (short) being the major variants. All isoforms contain the BH3 domain essential for their pro-apoptotic function[3].
BIM isoforms share common structural features:
The critical BH3 domain (approximately 16 residues) mediates:
BIM is a potent initiator of mitochondrial (intrinsic) apoptosis:
In neurons, BIM plays a critical role:
BIM integrates various stress signals:
BIM contributes to AD neuronal loss:
In PD:
In motor neuron disease:
BIM involvement includes:
Therapeutic strategies include:
The study of Bim Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
O'Connor et al. BIM in apoptosis (1998). 1998. ↩︎
Putcha et al. [BIM in neuronal apoptosis (2001)](https://doi.org/10.1016/S1097-2765(01). 2001. ↩︎
Biswas et al. BIM in neurodegeneration (2007). 2007. ↩︎
Shibata et al. BIM in ALS models (2010). 2010. ↩︎